top of page
RG_Assay_Box.jpg

THE GALD ASSAY

A Lectin-Based Quantification of Serum Galactose-deficient IgA1

Quantitative Assay
4-hour turn around 
96-well plate
Based on the Novak Assay
All-in-one easy to implement kit

Serum levels of Gd-IgA1 represent the most utilized disease-specific biomarker in IgA nephropathy

The GalD Assay will include calibration standards, QC's, blanks, and reagants to analyze 36 patient samples in duplicate.  

IgAN Patient vs Healthy Controls.png

IGAN PATIENT VS. HEALTHY CONTROLS

Statistically significant separation (p=0.0105) observed in Gd-IgA1 serum levels as measured by the GalD Assay
IgA nephropathy patients (n=29) and healthy controls (n=12)

LAUNCHING IN SPRING 2024

The GalD Assay from Reliant Glycosciences
*For research purposes only*

ADD YOUR NAME TO THE LIST

By adding your name to the list for The GalD Assay, we will follow up with you shortly!

Thanks for submitting!

bottom of page